Status:
COMPLETED
Screening for Hypercholesterolemia in Children Using Dried Blood Spot
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
2+ years
Brief Summary
Purpose: Heterozygous Familial Hypercholesterolemia (HeFH) is a common genetic disease responsible for premature atherosclerosis. Therefore, early diagnosis and initiation of a treatment early as at ...
Eligibility Criteria
Inclusion
- patients/kindreds in family with a documented history of hypercholesterolemia
- healthy subjects for controls
Exclusion
- refusal to participate in the study
- For control patients: to have a known dyslipidemia
Key Trial Info
Start Date :
May 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05191355
Start Date
May 18 2022
End Date
February 28 2023
Last Update
September 1 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon, Dept of Endocrinology
Bron, France, 69500
2
Hospices Civils de Lyon, Service d'Hépatologie et de Gastro-Entérologie et Nutrition Pédiatrique
Bron, France, 69500